RecruitingNCT04699292

International Prospective Registry on Local Treatment Approaches in MLS

Studying Liposarcoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
The Netherlands Cancer Institute
Principal Investigator
Rick Haas, MD/PhD
The Netherlands Cancer Institute
Intervention
Surgery(procedure)
Enrollment
300 enrolled
Eligibility
18 years · All sexes
Timeline
2021 – 2031

Study locations (1)

Collaborators

Radboud University Medical Center · Maastro Clinic, The Netherlands · University Medical Center Groningen · Leiden University Medical Center · Vienna General Hospital · M.D. Anderson Cancer Center · University Hospital, Antwerp · Universitetssykehus · Haukeland University Hospital · Universitäts-Frauenklinik Graz · University Hospital Heidelberg · Mayo Clinic · Aarhus University Hospital · National Cancer Center, Japan · Princess Margaret Hospital, Canada · MOUNT SINAI HOSPITAL · University of Sydney · Institute for Cancer Research and treatment · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · Institut Curie · Australia and New Zealand Sarcoma Association

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04699292 on ClinicalTrials.gov

Other trials for Liposarcoma

Additional recruiting or active studies for the same condition.

See all trials for Liposarcoma →

← Back to all trials